Chad Beyer, Ph.D., MBA

Chad Beyer, Ph.D., MBA is Senior Vice President of Research and Development at Promentis. He has over 20 years of experience in the research, discovery and development of medications aimed to treat CNS and neurological disorders. Prior to joining Promentis, Beyer served as the Head of Neurochemistry and led the Psychiatry Task Force at Wyeth Pharmaceuticals in Princeton, NJ. During his career at Wyeth, Beyer led several early-stage drug discovery teams and managed a group responsible for contributing to the commercialization and life-cycle management of two blockbuster medications.

As an Entrepreneur-in-Residence at the Dyer Center, Chad brings his experience in biotechnology, pharmaceuticals, and venture development to help students explore innovation at the intersection of science and business. He also teaches INDS 246: Biotechnology and Entrepreneurship, where students examine the commercialization of life science technologies, focusing on intellectual property, government policies, and market forces, while discussing ethical challenges and real-world strategies for bringing innovations to market.

Curious about biotechnology, pharmaceuticals, or how science becomes real-world innovation? Whether you’re exploring the biotech field or interested in careers that blend research and entrepreneurship, this is a great opportunity to learn from someone with hands-on industry experience.

Want to explore how your ideas could make an impact?
Email Chad Beyer to schedule a mentorship meeting.